Owl Executive Advisory (Owlea)
Modernizing Life Sciences Commercial Excellence Through Technology and AI
About Owl Executive Advisory (Owlea)
Owl Executive Advisory (Owlea) is an independent advisory practice specializing in helping pharmaceutical, medtech, and digital health organizations transform their commercial, service, and customer engagement capabilities. With 25 years of enterprise transformation experience across Top 30 pharma companies, we bring deep expertise in translating complex change into scalable, measurable outcomes. Our work spans the critical intersection of commercial technology, CRM, data, and applied AI—enabling organizations to modernize their operating models and unlock new value.
Led by Jan Eule, a former Accenture Managing Director, we advise senior leaders on platform strategy, operating model design, data foundations, and the practical, governed activation of AI and agentic capabilities. Whether you're evaluating Salesforce or Veeva implementations, designing transformation roadmaps, or exploring the latest in life sciences commercial technology, we combine strategic insight with hands-on execution experience to deliver measurable results.
Our Services
Platform Strategy & CRM Transformation
Platform Strategy & CRM Transformation Description: Expert guidance on Salesforce and Veeva platform strategy, CRM assessments, and implementation roadmaps. We help organizations design and execute transformations that align technology with commercial objectives and operating models.
AI and Data Foundations
Strategic advisory on building data foundations and activating AI and agentic capabilities across commercial and patient services workflows. We ensure governed, practical implementation that drives measurable business outcomes.
Executive Advisory & Transformation Strategy
Senior-level consulting on commercial modernization, operating model design, and transformation strategy. We also provide expert-network consultations supporting investors, strategy firms, and technology providers evaluating the life sciences commercial technology landscape.